Nanopatch immunisation against pandemic influenza: improved immune responses at a reduced dose. (2009–2011)

Development of a new way to vaccinate against influenza that will make standard vaccines 100 times more potent than conventional syringe injection. The Nanopatch is made from a silicon wafer, bristling with micro-nanoscale spikes. It painlessly deposits vaccine under the skin surface. Experiments in mice show that even a small vaccine payload delivered to the skin generates good immune responses. The Nanopatch vaccination system is expected to be ready for clinical trials within a few years.
Grant type:
NHMRC Project Grant
  • Adjunct Associate Professor
    School of Chemistry and Molecular Biosciences
    Faculty of Science
  • Professor
    Faculty of Medicine
    Affiliate Professor
    The University of Queensland Diamantina Institute
    Faculty of Medicine
    Affil Professorial Research Fellow
    Institute for Molecular Bioscience
Funded by:
National Health and Medical Research Council